Login
← Go Back
Alivus Life Sciences
ALIVUS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
2.6%
1w
5.5%
1m
13.4%
3m
3.0%
6m
5.6%
1y
34.2%
all
13.9%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun20Mar21Dec21Sep22Jun23Mar24Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,061 2.6%
867
1,260
Company Overview
Sales
2,274 Cr
Growth: -3.9%
Profit after Tax
442 Cr
Growth: 4.3%
Mid Cap
12,996 Cr
P/E: 29.5x
Industry P/E: 32.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 2,274
Growth -3.9%
EBITDA 27.5%
P/S 5.7x
Dividend 0.0%
P/E 29.5x
Book Value ₹ 218
PEG Ratio -7.5x
ROE 17.7%
P/B 4.9x
Shareholding Pattern
Institutions
Created with Highcharts 8.2.2Dec21Mar22Sep22Jun23Sep23Mar24Jun24Sep24Dec24
Promoters
Created with Highcharts 8.2.2Dec21Mar22Sep22Jun23Sep23Mar24Jun24Sep24Dec24
Others
Created with Highcharts 8.2.2Dec21Mar22Sep22Jun23Sep23Mar24Jun24Sep24Dec24
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (16 Indices) view more
Investors (5)
nirma
polar.ca...
santhosh...
Followers (2)
atharav
varsha96